None listed
Conditions
Interventions
Drug : After thoracoscopic surgery is completed, the intervention group receives an intravenous infusion of 1 g (100 cc) of acetphen premix(Acetaminophen) once over 15 minutes, and the control group r
Sponsors
Yonsei University, Wonju Severance Christian Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Among patients undergoing thoracic surgery, those who consented to pain management Age: 19 to 80 years old American Society of Anesthesiologist Physical Condition Classification Grades 1 to 4
Exclusion criteria
Exclusion criteria: Patients with cognitive decline, which makes it difficult to obtain information and the effect of nerve block related to the study Patients with contraindications to nerve block (INR > 1.3, PTT > 43 seconds without anticoagulant administration, coagulopathy, antiplatelet medication within 48 hours, dual antiplatelet therapy, treatment site infection, patient refusal of treatment, local anesthetic allergic reaction) Patients requiring anticoagulant therapy after surgery Pregnant woman Comorbidity: Any concomitant disease (sepsis, anatomical thoracic deformity, empyema, elevated intracranial pressure, etc.) for which the patient should be excluded from the study under the judgment of the anesthesiologist
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analog scale (VAS) score | — |
Secondary
| Measure | Time frame |
|---|---|
| Usage of opioid analgesic;satisfaction grade;Nausea and vomiting | — |
Countries
Korea, Republic of
Contacts
Public ContactSujin Ki,m
Yonsei University, Wonju Severance Christian Hospital
Outcome results
None listed